Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ARID1A, 26-BP DEL, NT31

 
National Institutes of Health

Related topics

Related topics

1 relation
MENTAL RETARDATION, AUTOSOMAL DOMINANT 14

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
ARID1A‐SIN3A drives retinoic acid‐induced neuroblastoma differentiation by transcriptional repression of TERT
Aggressive, high‐risk neuroblastoma (NB) exhibits an immature differentiation state, profound epigenetic dysregulation and high… Expand
Is this relevant?
Review
2019
Review
2019
Salivary Gland Fine Needle Aspiration and Introduction of the Milan Reporting System
Fine needle aspiration (FNA) is a well-established procedure for the diagnosis and management of salivary gland lesions despite… Expand
Is this relevant?
2015
2015
Comparative transcriptome analysis reveals that the extracellular matrix receptor interaction contributes to the venous metastases of hepatocellular carcinoma.
Hepatocellular carcinoma (HCC) is the most common type of liver cancer in the world. Portal vein tumor thrombus (PVTT) is one of… Expand
Is this relevant?
2012
2012
Mutations and deletions of ARID1A in breast tumors
Mamo et al. (2011) identified ARID1A as a candidate tumor suppressor gene (TSG) in breast cancer (BC) by an integrated genomic… Expand
  • figure 1
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
Recent genome-wide analysis has demonstrated that somatic mutations in ARID1A (BAF250) are the most common molecular genetic… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE